04:09:04 EST Tue 13 Jan 2026
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:HYFT - MINDWALK HOLDINGS CORP - https://www.mindwalkai.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
HYFT - Q3.02.53·3.270.12.61-0.11-4.02,654.76,5375,3872.99  2.99  2.103.2459  0.27Jan 12Jan 1215 min RT 2¢

Recent Trades - Last 10 of 5387
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-12 07:00U:HYFTNews ReleaseREPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
2026-01-09 20:01U:HYFTNews ReleaseMindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
2025-12-15 12:09U:HYFTSEDAR Interim Financial StatementsSEDAR Interim MD & A
2025-12-15 08:30U:HYFTNews ReleaseMindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline
2025-12-08 08:30U:HYFTNews ReleaseMindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 on December 15, 2025
2025-11-13 09:00U:HYFTNews ReleaseMindWalk CTO Dr. Dirk Van Hyfte to Join Fireside Chat at AI Drug Discovery & Development Summit 2025
2025-10-21 08:28U:HYFTNews ReleaseMindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
2025-10-15 07:00U:HYFTNews ReleaseMindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
2025-10-09 07:00U:HYFTNews ReleaseMindWalk Announces Share Repurchase Program
2025-09-22 07:02U:HYFTNews ReleaseMindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
2025-09-15 11:12U:HYFTSEDAR Interim MD & ASEDAR Interim MD & A
2025-09-15 11:06U:HYFTSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-09-15 08:44U:HYFTNews ReleaseMindWalk Holdings Corp.(TM) (formerly ImmunoPrecise Antibodies(TM)) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet
2025-09-10 08:16U:HYFTNews ReleaseMindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025